ACNE: History. Reality and Legends
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mask-Induced Acne Flare During Coronavirus Disease-19. What Is It and How to Manage It?
Scientific Foundation SPIROSKI, Skopje, Republic of Macedonia Open Access Macedonian Journal of Medical Sciences. 2020 Oct 31; 8(T1):411-415. https://doi.org/10.3889/oamjms.2020.5388 eISSN: 1857-9655 Category: T1 - Thematic Issue “Coronavirus Disease (COVID-19)” Section: Narrative Review Article MASKNE: Mask-Induced Acne Flare During Coronavirus Disease-19. What is it and How to Manage it? Laura Pauline Kosasih Department of Dermatology, Cardiff University, Cardiff, Wales, United Kingdom Abstract Edited by: Mirko Spiroski The coronavirus disease (COVID)-19 is a global pandemic caused by severe acute respiratory syndrome (SARS)- Citation: Kosasih LP. MASKNE: Mask Induced Acne Flare During Coronavirus Disease-19. What is it and How to CoV-2. Due to the rapid spread of the disease, several measures have been proposed to mitigate its transmission, Manage it? Open Access Maced J Med Sci. 2020 Oct 31; including wearing a mask in certain circumstances. This new proposition leads to some novel skin adverse effects; 8(T1):411-415. one of them is acne flare. This particular outbreak has significantly affected people’s quality of life. In this minireview, https://doi.org/10.3889/oamjms.2020.5388 Keywords: Acne; MASKNE (Mask Acne); a brief current knowledge of SARS-CoV-2 and its related-acne-flare, or popularly called as mask-acne (MASKNE), Coronavirus Disease-19 are discussed. This review aims to provide some information that may be helpful in opting for the most suitable *Correspondence: Laura Pauline Kosasih, Department of Dermatology, Cardiff -
Mineral Makeup and Its Role with Acne and Rosacea Jane Iredale, MA; Jennifer Linder, MD
REVIEW Mineral Makeup and Its Role With Acne and Rosacea Jane Iredale, MA; Jennifer Linder, MD Rosacea and acne have been the cause of physical and emotional distress for patients worldwide. Part of the distress has originated from the inability to find products that provide coverage without exacerbating the conditions. This includes understanding the role of certain ingredients with their attendant negative and positive effects. Fifteen years of experience has shown that mineral makeup can play a large part in helping to repair patients’ self-esteem as well as playing a meaningful role in skin improvement. IDENTIFYING AUTHENTIC For physicians to assess mineral makeup and its ben- MINERAL MAKEUP efits for their patients with rosacea and acne, it is neces- Patients with acne and rosacea frequently seek options to sary to explore the chemical composition of authentic cover what they consider toCOS be visually frustrating condi- DERMmineral powder. Many makeup brands are now mar- tions. Regrettably, they often make choices that are not keting products they call mineral makeup, but they effective and potentially detrimental to their situation. do not utilize authentic minerals in their formulations. To serve these patients better, physicians should educate The incorrect use of the word mineral as a marketing themselves and their staffs about camouflaging options. term confuses patients and can lead to the use of prod- Mineral makeup can beDo a satisfactory solutionNot as it is a ucts Copythat can potentially worsen their condition due to healthy, skin-friendly alternative to traditional makeup. problematic ingredients. Mineral makeup not only provides superior coverage and The original definition of mineral makeup is a makeup is easy to use, but it is also UV protective, noncomedo- that eliminates talc, potential skin irritants, and comedo- genic, and anti-inflammatory. -
United States Patent (19) 11 Patent Number: 5,994,330 El Khoury (45) Date of Patent: Nov.30, 1999
USOO599433OA United States Patent (19) 11 Patent Number: 5,994,330 El Khoury (45) Date of Patent: Nov.30, 1999 54 TOPICAL APPLICATION OF MUSCARINIC S. Abram, MD et al., Anesth Analg., “Intrathecal Acetyl AGENTS SUCH AS NEOSTIGMNE FOR Cholinesterase Inhibitors Produce Analgesia That is Syner TREATMENT OF ACNE AND OTHER gistic with Morphine and Clonidine in Rats, 81:501-7 NFLAMMATORY CONDITIONS (1995). C. Stein, M.D. et al., New England Journal of Medicine, vol. 76 Inventor: Georges F. El Khoury, 1561 Ramillo 325, No. 16 “Analgesic Effect of Intraarticular Morphine Ave., Long Beach, Calif. 90815 After Arthroscopic Knee Surgery, pp. 1123-1126. T. Yaksh, Ph.D. et al., Anesthesiology, “Studies on the Safety 21 Appl. No.: 09/188,328 of Chronically Administered Intrathecal Neostigmine Meth 22 Filed: Nov. 9, 1998 ylsulfate in Rats and Dogs,” V 82. No. 2, Feb. 1995. “Morphine-A Local Analgesic, International ASSocia (51) Int. Cl." ..................................................... A01N 57/00 tion for the Study of Pain, vol. III. 52 U.S. Cl. .......................... 514/123; 514/123; 514/859; G. Lauretti, MD et al., Anesth Analg “The Effects of 514/855; 514/289; 514/912; 514/78.04; Intrathecal Neostigmine on Somatic and Visceral Pain: 424/401 Improvement by Associate with a Peripheral Anticholin 58 Field of Search ........................... 424/401; 536/55.1; ergic,” 81:615–20 (1996). 514/912, 78.04, 289, 859, 123,855 D. Hood, M.D., et al., Anesthesiology, “Phase I Safety Assessment of Intrathecal Neostigmine Methylsulfate in 56) References Cited Humans,” V 82, No. 2, Feb. 1995 pp. 331-342. U.S. -
Canadian Clinical Practice Guideline on the Management of Acne (Full Guideline)
Appendix 4 (as supplied by the authors): Canadian Clinical Practice Guideline on the Management of Acne (full guideline) Asai, Y 1, Baibergenova A 2, Dutil M 3, Humphrey S 4, Hull P 5, Lynde C 6, Poulin Y 7, Shear N 8, Tan J 9, Toole J 10, Zip C 11 1. Assistant Professor, Queens University, Kingston, Ontario 2. Private practice, Markham, Ontario 3. Assistant Professor, University of Toronto, Toronto, Ontario 4. Clinical Assistant Professor, University of British Columbia, Vancouver, British Columbia 5. Professor, Dalhousie University, Halifax, Nova Scotia 6. Associate Professor, University of Toronto, Toronto, Ontario 7. Associate Clinical Professor, Laval University, Laval, Quebec 8. Professor, University of Toronto, Toronto, Ontario 9. Adjunct Professor, University of Western Ontario, Windsor, Ontario 10. Professor, University of Manitoba, Winnipeg, Manitoba 11. Clinical Associate Professor, University of Calgary, Calgary, Alberta Appendix to: Asai Y, Baibergenova A, Dutil M, et al. Management of acne: Canadian clinical practice guideline. CMAJ 2015. DOI:10.1503/cmaj.140665. Copyright © 2016 The Author(s) or their employer(s). To receive this resource in an accessible format, please contact us at [email protected]. Contents List of Tables and Figures ............................................................................................................. v I. Introduction ................................................................................................................................ 1 I.1 Is a Clinical Practice Guideline -
International Journal of Scientific Research
ORIGINAL RESEARCH PAPER Volume-9 | Issue-1 | January-2020 | PRINT ISSN No. 2277 - 8179 | DOI : 10.36106/ijsr INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH TYPES AND VARIANTS OF ACNE Dermatology Shailee Patel ABSTRACT Acne occur when pores of skin are blocked with oil, dead skin, or bacteria. It can occur when excessive oil is produced by follicles, bacteria build up in pores, and dead skin cells accumulate in pores. All these problem contribute in development of pimple. Acne are majorly seen among teenagers but they can also occur in adults. There are varying from of acne, and their varying treatment. KEYWORDS 1.INTRODUCTION ulcerative colitis and Crohn's disease and syndromes, such as Acne is linked to the change in hormone level during puberty. Acne is a synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) and disorder that is seen worldwide. Acne is a disease of the teenagers but pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) can be seen even in newborn children and also adults. Age and gender syndromes. also play a very important role in onset of acne. Acne most commonly occur between the ages of 10-13 years. Girls have an earlier onset 3.4 Occupational Acne which easily contribute to the onset of puberty in girls than in boys. The Occupational acne is defined as development of acne-like lesions after disease severity in more in boys during the late adolescence. Acne exposure to occupational agents in persons not prone to develop acne mostly develops on areas of skin that have abundant oil glands, like the and who have not had acne before engaging in the said occupation. -
A Comprehensive Review of Acne Vulgaris AK Mohiuddin1* 1Department of Pharmacy, World University of Bangladesh
Symbiosis ISSN Online: 2378-1726 www.symbiosisonlinepublishing.com Review Article Clinical Research in Dermatology: Open Access Open Access A Comprehensive Review of Acne Vulgaris AK Mohiuddin1* 1Department of Pharmacy, World University of Bangladesh Received: May 25, 2019; Accepted: June 6, 2019; Published: June 17, 2019 *Corresponding author: AK Mohiuddin, Assistant Professor, Department of Pharmacy, World University of Bangladesh, 151/8, Green Road, Dhanmondi, Dhaka – 1205, Bangladesh. E-mail: [email protected]; Orcid Id: https://orcid.org/0000-0003-1596-9757. Abstract Acne, also known as acne vulgaris (AV), is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin. It is characterized by blackheads or whiteheads, pimples, oily skin, and possible scarring. An intact stratum corneum and barrier, normal natural moisturizing factor and hyaluronic acid levels, normal Aquaporin-3 (AQP3) expression (localized at the basal lateral membranes of collecting duct cells in the kidney), and balanced sebum secretion are qualities of the skin that fall in the middle of the oily–dry spectrum. Patients rarely, if ever, complain about reduced sebum production, but elevated sebum production, yielding oily skin that can be a precursor to acne, is a common Propionibacterium acnes in adolescence, under the complaint. Several factors are known to influence sebum production. AV is mostly triggered by impact,influence as of sebum normal levels circulating are usually dehydroepiandrosterone low in childhood, rise (DHEA). in the middle-to-late It is a very common teen years, skin disorder and remain which stable can presentinto the withseventh inflammatory and eighth and decades non- untilinflammatory endogenous lesions androgen chiefly synthesis on the face dwindles. -
Acne Vulgaris
Seminar Acne vulgaris Hywel C Williams, Robert P Dellavalle, Sarah Garner Acne is a chronic infl ammatory disease of the pilosebaceous unit resulting from androgen-induced increased sebum Lancet 2012; 379: 361–72 production, altered keratinisation, infl ammation, and bacterial colonisation of hair follicles on the face, neck, chest, Published Online and back by Propionibacterium acnes. Although early colonisation with P acnes and family history might have important August 30, 2011 roles in the disease, exactly what triggers acne and how treatment aff ects the course of the disease remain unclear. DOI:10.1016/S0140- 6736(11)60321-8 Other factors such as diet have been implicated, but not proven. Facial scarring due to acne aff ects up to 20% of This publication has teenagers. Acne can persist into adulthood, with detrimental eff ects on self-esteem. There is no ideal treatment for been corrected. acne, although a suitable regimen for reducing lesions can be found for most patients. Good quality evidence on The corrected version fi rst comparative eff ectiveness of common topical and systemic acne therapies is scarce. Topical therapies including appeared at thelancet.com benzoyl peroxide, retinoids, and antibiotics when used in combination usually improve control of mild to moderate on January 27, 2011 acne. Treatment with combined oral contraceptives can help women with acne. Patients with more severe infl ammatory Centre of Evidence-Based Dermatology, Nottingham acne usually need oral antibiotics combined with topical benzoyl peroxide to decrease antibiotic-resistant organisms. University Hospitals NHS Oral isotretinoin is the most eff ective therapy and is used early in severe disease, although its use is limited by Trust, Nottingham, UK teratogenicity and other side-eff ects. -
Review on Acne Cosmetica with Management by Vishaghan Mahakashay and Lodhradi Lepa
wjpmr, 2018,4(11), 105-109 SJIF Impact Factor: 4.639 Review Article WORLD JOURNAL OF PHARMACEUTICAL Sharma et al. AND MEDICAL RESEARCH World Journal of Pharmaceutical and Medical ResearchISSN 2455 -3301 www.wjpmr.com WJPMR REVIEW ON ACNE COSMETICA WITH MANAGEMENT BY VISHAGHAN MAHAKASHAY AND LODHRADI LEPA Dr. Kirti Sharma*1, Dr S.R. Inchulkar2 and Dr. Prafulla3 1P.G. Scholar, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College, Raipur (C.G.). 2Professor & HOD, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College Raipur (C.G.). 3Reader, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College, Raipur (C.G.). *Corresponding Author: Dr. Kirti Sharma P.G. Scholar, Department of Agad Tantra evam Vidhi Vaidyak, Govt Ayurvedic College, Raipur (C.G.). Article Received on 09/09/2018 Article Revised on 30/09/2018 Article Accepted on 21/10/2018 ABSTRACT Acne cosmetica is an inflammation of pilosebaceous follicle of certain body areas occurs commonly in 80% adolescence. It is a condition which occurs due to the use of certain makeup and cosmetics products, seen on the skin area where the beauty product is applied. Acne cosmetica was described at the first time by Kligman and Mills in 1972. In Ayurveda Acne cosmetica comes under mukhdushika, Cosmetics and beauty products having various chemical and these are considered as kritrim visha. kritrimavisha (Artificial poisons) is prepared by the combination of various animate, inanimate poisons. Acharya Charak described Vishghna mahakashaya and Acharya Sharangadhara mentioned lodhradi lepa can be a better choice for the treatment of Acne cosmetica or mukhdushika, by its antitoxic effect, blood purification and varnya (skin complexion) property. -
Acne and Related Conditions
Rosanne Paul, DO Madeline Tarrillion, DO Miesha Merati, DO Gregory Delost, DO Emily Shelley, DO Jenifer R. Lloyd, DO, FAAD American Osteopathic College of Dermatology Disclosures • We do not have any relevant disclosures. Cleveland before June 2016 Cleveland after June 2016 Overview • Acne Vulgaris • Folliculitis & other – Pathogenesis follicular disorders – Clinical Features • Variants – Treatments • Rosacea – Pathogenesis – Classification & clinical features • Rosacea-like disorders – Treatment Acne vulgaris • Pathogenesis • Multifactorial • Genetics – role remains uncertain • Sebum – hormonal stimulation • Comedo • Inflammatory response • Propionibacterium acnes • Hormonal influences • Diet Bolognia et al. Dermatology. 2012. Acne vulgaris • Clinical Features • Face & upper trunk • Non-inflammatory lesions • Open & closed comedones • Inflammatory lesions • Pustules, nodules & cysts • Post-inflammatory hyperpigmentation • Scarring • Pitted or hypertrophic Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Acne variants • Acne fulminans • Acne conglobata • PAPA syndrome • Solid facial edema • Acne mechanica • Acne excoriée • Drug-induced Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Acne variants • Occupational • Chloracne • Neonatal acne (neonatal cephalic pustulosis) • Infantile acne • Endocrinological abnormalities • Apert syndrome Bolognia et al. Dermatology. 2012. Bolognia et al. Dermatology. 2012. Acne variants • Acneiform -
(12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr
USOO7359748B1 (12) United States Patent (10) Patent No.: US 7,359,748 B1 Drugge (45) Date of Patent: Apr. 15, 2008 (54) APPARATUS FOR TOTAL IMMERSION 6,339,216 B1* 1/2002 Wake ..................... 250,214. A PHOTOGRAPHY 6,397,091 B2 * 5/2002 Diab et al. .................. 600,323 6,556,858 B1 * 4/2003 Zeman ............. ... 600,473 (76) Inventor: Rhett Drugge, 50 Glenbrook Rd., Suite 6,597,941 B2. T/2003 Fontenot et al. ............ 600/473 1C, Stamford, NH (US) 06902-2914 7,092,014 B1 8/2006 Li et al. .................. 348.218.1 (*) Notice: Subject to any disclaimer, the term of this k cited. by examiner patent is extended or adjusted under 35 Primary Examiner Daniel Robinson U.S.C. 154(b) by 802 days. (74) Attorney, Agent, or Firm—McCarter & English, LLP (21) Appl. No.: 09/625,712 (57) ABSTRACT (22) Filed: Jul. 26, 2000 Total Immersion Photography (TIP) is disclosed, preferably for the use of screening for various medical and cosmetic (51) Int. Cl. conditions. TIP, in a preferred embodiment, comprises an A6 IB 6/00 (2006.01) enclosed structure that may be sized in accordance with an (52) U.S. Cl. ....................................... 600/476; 600/477 entire person, or individual body parts. Disposed therein are (58) Field of Classification Search ................ 600/476, a plurality of imaging means which may gather a variety of 600/162,407, 477, 478,479, 480; A61 B 6/00 information, e.g., chemical, light, temperature, etc. In a See application file for complete search history. preferred embodiment, a computer and plurality of USB (56) References Cited hubs are used to remotely operate and control digital cam eras. -
Epidemiology of Acne Vulgaris (Excluding Acne Rosacea, Infantile Acne, Acne Inversa)
K. Bhate Centre of Evidence Based Dermatology University of Nottingham Overview Background Objectives and Method Findings Incidence Natural history Morbidity Socioeconomic impact Overview - 2 Genetics Ethnicity Diet Sunlight Hygiene Smoking Obesity Stress Infection One or two others.. Conclusion Background Epidemiology Incidence Prevalence Age, sex, social class Ethnic group and geography Natural history Risk factors for disease occurrence or progression Why is it important? Objective To provide a comprehensive review on the Epidemiology of Acne vulgaris (excluding acne rosacea, infantile acne, acne inversa) Baseline for future work Provocation trial Cohort study Methods Medline database (in process and other non-indexed citations 1946-present) Embase 1974 to the end of January 2012 NHS Evidence Acne vulgaris with epidemiology, aetiology, cause, prevalence, incidence, cost, pharmacoeconomics, socioeconomic, natural history, race, ethnicity, morbidity, quality of life, geography, family size, severity, excoriation, obesity, overweight, pathogenesis, washing, sweat, cleanse, sun, sunlight, light, diet, dairy, milk, GI, high GI, glycaemic/glycemic index, chocolate, hygiene, smoking, prevention, climate, environment, obesity, infection, Propionibacterium acnes (P. acnes), stress, picking, chloracne, drugs and medicine. Truncation to expand upon suffices No use of additional limits No pre-specified criteria for study exclusion or inclusion Results and Outcome Measures 173 papers included! Outcome measures How common is acne? All people between 15 and 17 15-20% classified as moderate to severe Prevalence data and 1996 census data - prevalence rate in 12-24 year olds 50% of 10 and 11 year old have more than 10 comedones and almost 80% of 8.5-12.2 year old had a degree of acne How long does acne last? Pre-pubertal children tend to have non-inflammatory acne – no sebum therefore no P. -
Military Dermatology, Index
Index INDEX A Alkalis and acids and irritant contact dermatitis, 132 Abdomen Allen, Alfred M., 5, 112, 396, 425 and contact dermatitis, 136 Allergic contact dermatitis, 113-131 Achiya, Michihiko, 70, 71 and cashew, 118-119 Acids and clothing, 129-130 See Alkalis and acids and fragrances, 131 Acquired immunodeficiency syndrome (AIDS) and ginkgo, 119-120 and atypical mycobacterial infections, 404, 417 and Gluta, 120 and cryptococcosis, 481 and India marking nut tree, 117 and genital herpes infection, 531 and Japanese lacquer tree, 117-118 and leprosy, 352 and mango, 118 and molluscum contagiosum, 580-581 and metals, 125-128 and secondary syphilis, 503 and miscellaneous sensitizers, 131 and tuberculosis, 376, 377, 379 and plants, 113-114 See also Immunocompromised patients geographical distribution, 120-123 Acrocyanosis, 33 and poison ivy and poison oak, 114-117 clinical manifestations, 33 and poison sumac, 117 etiology, 33 and preservatives, 130-131 treatment, 33 and rubber compounds, 129 Acrodermatitis chronica atrophicans, 311 and shoes, 128-129 Actinomycosis, 483-485 and sunscreens, 125 Africa and topical drugs, 123-125 and dracunculiasis, 279 See also Atopic dermatitis; Contact dermatitis; Irritant and filariasis, 274 contact dermatitis and histoplasmosis, 457 Almeida, Louis, 323 and loiasis, 276 Altman, J., 562 and lymphogranuloma venereum, 522 Amebiasis, 268-269 and mycetoma, 476 clinical manifestations, 269-269 and onchocerciasis, 277, 278 diagnosis, 269 and schistosomiasis, 281 treatment, 269 and streptocerciasis, 279 Amenhotep